What are the primary applications?

It is used in the food industry, health supplements, and medicine, available in paste, tablet, or capsule forms.

What is the lead time for orders?

Lead time is within 15 workdays during off-season and one month during peak season.

White Kidney Bean Extract Powder Phaseolin 4: 1 10: 1 20: 1

Name: White Kidney Bean Extract Powder Phaseolin 4: 1 10: 1 20: 1
Brand: QINGDAO HILDA-JINGYI TRADING CO., LTD.
SKU: 1949099762

Shandong, ChinaQINGDAO HILDA-JINGYI TRADING CO., LTD.

US$1.00-50.00

1 kg

Product profile

Customization

Available

Certification

BRC, ISO, HACCP

Assay Method

HPLC

Model NO.

Application Form

Paste, Tablet, Capsule

Application

Food, Health Care Products, Medicine

State

Powder

MOQ

1kg

Shelf Life

24 Months

Appearance

White Powder

Transport Package

25kgs/Drum

Specification

10: 1

Trademark

HDJY

Origin

China

Production Capacity

1000tons

Key features

Natural Amylase Inhibitor: Contains phaseolin, a natural amylase inhibitor more effective than wheat extracts for weight management.

Multi-Standard Certified: Certified by BRC, ISO, and HACCP, ensuring high quality and safety for global markets.

Versatile Applications: Suitable for food, health supplements, and medicine in paste, tablet, or capsule forms.

Flexible Specifications: Available in various concentrations from 1% to 50% phaseolin content via HPLC testing.

Rich Nutrient Profile: Contains plant lectins, polysaccharides, dietary fiber, flavonoids, and essential amino acids.

Health Benefits: Supports spleen and kidney health, regulates qi, and aids in managing obesity and diabetes.

Company profile

QINGDAO HILDA-JINGYI TRADING CO., LTD.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2012-06-02Nearest Port: QINGDAO, TIANJIN,SHANGHAI,DALIAN,XIAMENAverage Response Time: ≤9.11hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAP, CIP, FCA, EXW

AI-Powered supplier vetting

SummaryQINGDAO HILDA-JINGYI TRADING CO., LTD. is a China-based limited company in Qingdao, Shandong, described as both a trading company and manufacturer/factory. It reports more than 10 production lines, substantial stated output across seaweed, spirulina, and chlorella products, and exports to multiple global regions, with exports representing 90% of sales. The supplier lists BRC, ISO 9001, ISO 22000, GMP, and HACCP management certifications, while some certifications are attributed to joint manufacturers rather than clearly to the supplier itself. Six to ten R&D engineers and six to ten quality-control staff are reported. Evidence is insufficient to confirm after-sales service processes, customization capability, or robust customer cases. Financial credibility cannot be assessed from the permitted non-financial evidence.

Supplier typeThe supplier is identified as a China-based limited company in Qingdao and is described as both a trading company and manufacturer/factory. However, another slice categorizes the company as a trade company, so its own manufacturing role versus its trading or partner-manufacturer role is not fully clear.

CertificationsThe supplier lists BRC, ISO 9001, ISO 22000, GMP, and HACCP management-system certifications. However, the description says many joint manufacturers passed several certifications, so the evidence does not consistently establish that every certification is held directly by the supplier.

R&D capabilityThe supplier reports six to ten R&D engineers and offers products including algae extracts such as chlorella extract and phycocyanin, indicating some product-development capacity. No specific R&D projects, patents, new-product results, or technical achievements are stated.

Production capacityThe supplier reports more than 10 production lines and stated annual capacities of 10,000 tons of dried laminaria, 2,000 tons of frozen wakame, 5,000 tons of sushi nori, 1,000 tons of spirulina, and 400 tons of chlorella. Its dual trading/manufacturer description and references to joint manufacturers mean the extent of directly controlled production is not fully verified, but the reported capacity is substantial.